Alfred E. Mann
…pharmaceutical company, Sanofi, for US$925 million. Mann was chairman of the board of MannKind Corporation, a biomedical company, where he also served as chief executive officer until January 12, 2015. In November 2015, Hakan Edstrom stepped down as CEO and president and will remain until July, 2017 to provide other services…